B. Mellein

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial

Thomas J. Schnitzer, Gerd R Burmester, Eduardo Mysler et al. · The Lancet · 2004 · 702 citations

Medicine, Pharmacology, Pharmacotherapy +15

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial

Michael E. Farkouh, Howard S. Kirshner, Robert A. Harrington et al. · The Lancet · 2004 · 490 citations

Medicine, Pharmacology, Pharmacotherapy +13

Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib

Michael E. Farkouh, Jeffery Greenberg, Raban Jeger et al. · Annals of the Rheumatic Diseases · 2007 · 123 citations

Medicine, Pharmacology, Pharmacotherapy +17

Randomised double blind controlled trial of cyclosporin in multiple sclerosis.

Peter Rudge, J.C. Koetsier, J. Mertin et al. · Journal of Neurology Neurosurgery & Psychiatry · 1989 · 86 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +8

SAFETY, TOLERABILITY, AND EFFICACY OF CYCLOSPORINE MICROEMULSION IN HEART TRANSPLANT RECIPIENTS: A RANDOMIZED, MULTICENTER, DOUBLE-BLIND COMPARISON WITH THE OIL-BASED FORMULATION OF CYCLOSPORINE???RESULTS AT 24 MONTHS AFTER TRANSPLANTATION1

Howard J. Eisen, Robert E. Hobbs, Stacy F. Davis et al. · Transplantation · 2001 · 46 citations

Medicine, Pharmacokinetics, Pharmacology +17